Parkinson's Trial NCT07010783
Improve inspiratory strength and fitness
- Trial ID
- NCT07010783
- Official Title
- Investigation of Respiratory Functions, Inspiratory Muscle Strength, Physical Fitness and Aerobic Capacity in Patients With Parkinson's Disease
- Goal
- Improve inspiratory strength and fitness
- Status
- RECRUITING
- Sponsor
- Ankara University
- Study Type
- OBSERVATIONAL
- Enrollment
- 100 participants
- Conditions
- Parkinson Disease
Summary For Families
Researchers are mapping how Parkinson's affects breathing and exercise capacity, aiming to clarify problems with respiratory function and inspiratory muscle strength that can make daily activity harder and guide rehab and safety. Participants will have noninvasive tests of lung function, measurements of how much pressure the inspiratory muscles can generate, and fitness or aerobic capacity tests that show how well the heart and lungs support activity, no drug or device is given. Adults 50 to 80 with a neurologist-confirmed Parkinson's diagnosis and a Mini Mental State Examination score of 24 to 30 can join, while people who cannot communicate verbally, who use a walking aid, who have severe vision problems or other neurological disease, who have congestive heart failure, or who are not cleared to exercise are excluded.
Locations
- Atılım University, Ankara, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. Researchers are mapping how Parkinson's affects breathing and exercise capacity, aiming to clarify problems with respiratory function and inspiratory muscle strength that can make daily activity harder and guide rehab and safety. Participants will have noninvasive tests of lung function, measurements of how much pressure the inspiratory muscles can generate, and fitness or aerobic capacity tests that show how well the heart and lungs support activity, no drug or device is given. Adults 50 to 80 with a neurologist-confirmed Parkinson's diagnosis and a Mini Mental State Examination score of 24 to 30 can join, while people who cannot communicate verbally, who use a walking aid, who have severe vision problems or other neurological disease, who have congestive heart failure, or who are not cleared to exercise are excluded.
- Who can participate?
- Participants must be between 50 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 9 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.